SCHEMBL10698677

SCHEMBL10698677

Cc1nnc2n1-c1ccc(OCCCN3CCOCC3)cc1C(c1ccccc1)=NC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 7/20 0.56
GABRA5 P31644 7/20 0.56
GABRA2 P47869 7/20 0.56
GABRB2 P47870 6/20 0.56
GABRA3 P34903 5/20 0.56
OPRK1 P41145 3/20 0.56
BRD4 O60885 2/20 0.56
HPGD P15428 2/20 0.56
LMNA P02545 1/20 0.56
CNR1 P21554 1/20 0.56
OXTR P30559 1/20 0.47
AVPR1A P37288 1/20 0.47
FGFR1 P11362 1/20 0.44
SRC P12931 1/20 0.44
GABRG2 P18507 1/20 0.43
HTR2A P28223 1/20 0.43
GABRB3 P28472 1/20 0.43
ADRA1A P35348 1/20 0.43
PDE4D Q08499 1/20 0.43
PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10694618 0.96 GABRA1 (0.56) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL10694413 0.88 MAPK1 (0.45) LMNAFGFR1SRCHTR2APPARG
SCHEMBL10693440 0.84 GABRA1 (0.60) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL7318994 0.79 GABRA1 (0.71) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL10694270 0.79 GABRA1 (0.62) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL10694252 0.76 GABRA1 (0.58) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL10691840 0.74 PTAFR (0.68) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL11718805 0.72 OPRK1 (0.54) GABRA1GABRA5GABRA2GABRB2GABRA3
Alprazolam SCHEMBL8398 0.72 GABRA1 (1.00) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL8250450 0.72 GABRA1 (0.74) GABRA1GABRA5GABRA2GABRB2GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0255028-A2 1,4-Benzodiazepines, their preparation and use as PAF antagonists BOEHRINGER INGELHEIM KG (DE) 1988-02-03 EP disclosed